Elizabeth Ferreira De Pádua - Infectious Diseases

Author Information

Elizabeth Ferreira De Pádua is a researcher affiliated with the National Health Institute Doctor Ricardo Jorge, specifically within the Department of Infectious Diseases at the Laboratório de Referência da SIDA in Lisbon, Portugal. Her work primarily focuses on infectious diseases, with a particular emphasis on viral infections such as Hepatitis C and HIV.

Research Contributions

Elizabeth Ferreira De Pádua has made significant contributions to the field of infectious diseases. Her research has explored various aspects of Hepatitis C and HIV, including viral diversity, drug resistance, and the epidemiology of these infections among specific populations such as drug users. She has also been involved in studies related to the introduction and dynamics of SARS-CoV-2 in Portugal, showcasing her engagement with contemporary public health challenges. Notable studies include the assessment of Hepatitis C virus diversity and resistance mutations in co-infected individuals, as well as the genetic profiling of HIV-1 strains in pregnant women in the Lisbon area.

Aliases

Elizabeth Ferreira De Pádua is also known by several aliases, including E. Pádua, E. Padua, Elizabeth Pádua, and Elizabeth Padua.

Publication and Citation Metrics

Metric	Value
Total Citation Count	224
h-index	7
Total Paper Count	26

Publications:

SARS-CoV-2 introductions and early dynamics of the epidemic in Portugal

DOI: 10.1038/s43856-022-00072-0

Year: 2022

THU-422-Referral, treatment uptake and self-reported barriers in drug users diagnosed with active hepatitis C attending a low-threshold methadone program in Lisbon

DOI: 10.1016/S0618-8278(19)30669-3

Year: 2019

Old age, urinary obstruction and high lactate levels are risk factors to develop septic shock in urosepsis. A retrospective analysis.

DOI: 10.1016/s1569-9056(18)31791-3

Year: 2018

Hepatitis C in a Mobile Low-Threshold Methadone Program

DOI: 10.1097/MEG.0000000000000843

Year: 2017

National serological survey – Portugal 2015–2016: Study design

DOI: 10.1016/J.JCV.2016.08.219

Year: 2016

Genetic diversity and drug resistance profiles of human immunodeficiency virus type 1 (HIV-1) strains infecting pregnant women in the Greater Lisbon

DOI: 10.1016/J.JCV.2016.08.182

Year: 2016

[Assessment of Hepatitis C Virus Diversity in Addition to the Frequency of Genotypes in Samples Analyzed Between 2009 and 2014 at the Reference Laboratory of National Health Institute Dr. Ricardo Jorge].

DOI: 10.20344/AMP.6257

Year: 2015

Molecular characterization of hepatitis C virus for determination of subtypes and detection of resistance mutations to protease inhibitors in a group of intravenous drug users co‐infected with HIV

DOI: 10.1002/jmv.24213

Year: 2015

Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay

DOI: 10.1002/jmv.23545

Year: 2013

Genotypic resistance profiles to antiretroviral drugs in HIV-1 circulating among injecting drug users in the great Lisbon

DOI:

Year: 2013

How Effective are HIV Antivirals?

What is a Virus?

How Does WHO Respond to Disease Outbreaks?

What are the controversies surrounding Dengvaxia?

Why is Artemisinin Important in Malaria Treatment?

What is an Apicoplast?

What is the Role of the FDA in Infectious Diseases?

What Factors Influence Prevalence?

How are Funds Allocated?

What are the Symptoms of Yellow Fever?

Partnered Content Networks

Relevant Topics